Barclays Maintains Overweight on HCA Healthcare, Raises Price Target to $367
HCA Holdings, Inc. -0.63% Pre
HCA Holdings, Inc. HCA | 408.17 408.17 | -0.63% 0.00% Pre |
Barclays analyst Andrew Mok maintains HCA Healthcare (NYSE:
HCA) with a Overweight and raises the price target from $356 to $367.